About Normunity
Normunity is a private company based in Boston, Massachusetts, incorporated in 2020 in Delaware. It has reported $83,363,302 raised in two offerings on Form D since January 2022. Its chief executive is Sakae Asanuma.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 10, 2025 | Jan 14, 2025 | $37,500,000of $75.0M target | 13 | $2.8M | EquityRule 506(b) | Form D ↗ |
| Jan 11, 2022 | Jan 13, 2022 | $45,863,302of $68.7M target | 13 | $3.5M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $83,363,302 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Normunity's Form D filed Jan 14, 2025.
DP
David Parry
Venture Partner at Samsara BioCapital and director
First appears on the Form D that Normunity filed on January 14, 2025; on 1 of its 2 filings.
SN
Sara Nayeem
EVP, Investments at Enavate Sciences and director
First appears on the Form D that Normunity filed on January 14, 2025; on 1 of its 2 filings.
TS
Timothy Shannon
Chairman of the Board
On every Form D that Normunity has filed: 2 filings, from Jan 13, 2022 to Jan 14, 2025.
SA
Sakae Asanuma
President & CEO, Taiho Ventures, director
On every Form D that Normunity has filed: 2 filings, from Jan 13, 2022 to Jan 14, 2025.
DH
Darlene Deptula-Hicks
Executive officer
First appears on the Form D that Normunity filed on January 14, 2025; on 1 of its 2 filings.
MP
Marie-Claire Peakman
Director
First appears on the Form D that Normunity filed on January 14, 2025; on 1 of its 2 filings.
Marie-Claire Peakman appears on 2 Form D filings at 2 companies:
- Normunity, director: Jan 14, 2025
- Mediar Therapeutics, director: Dec 23, 2025

Paulina Hill
Director
First appears on the Form D that Normunity filed on January 14, 2025; on 1 of its 2 filings.
Paulina Hill appears on 6 Form D filings at 4 companies:
- NextPoint Therapeutics, board member: Dec 27, 2022 · Feb 14, 2024 · Jul 30, 2026
- Avilar Therapeutics, director: Feb 13, 2023 (amended)
- Normunity, director: Jan 14, 2025
- Odyssey Therapeutics, director: Dec 4, 2025
DR
Debanian Ray
Director
First appears on the Form D that Normunity filed on January 14, 2025; on 1 of its 2 filings.

Rachel Humphrey
Founding Chief Executive Officer and director
On every Form D that Normunity has filed: 2 filings, from Jan 13, 2022 to Jan 14, 2025.
Earlier filings also listed
- Yunxia Yang · directorLast listed on the Form D that Normunity filed on January 13, 2022; on 1 of its 2 filings.
- Scott Phillips · executive officerLast listed on the Form D that Normunity filed on January 13, 2022; on 1 of its 2 filings.
- James Trenkle · directorLast listed on the Form D that Normunity filed on January 13, 2022; on 1 of its 2 filings.
